Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 914998 | ISIN: BE0003766806 | Ticker-Symbol: IOB
Tradegate
10.05.24
11:27 Uhr
14,200 Euro
+0,020
+0,14 %
Branche
Sonstige Technologie
Aktienmarkt
BEL Mid
1-Jahres-Chart
ION BEAM APPLICATIONS SA Chart 1 Jahr
5-Tage-Chart
ION BEAM APPLICATIONS SA 5-Tage-Chart
RealtimeGeldBriefZeit
14,04014,26010.05.
14,12014,22010.05.

Aktuelle News zur ION BEAM APPLICATIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
02.05.IBA SA: IBA signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, US3
11.04.IBA SA: Iba - Transparency Notification7
21.03.Ion Beam Applications SA reports FY results; reaffirms medium-term guidance11
21.03.IBA SA: IBA Reports Full Year 2023 Results227GROUP REVENUES UP 18.7% WITH OTHER ACCELERATORS UP 51.1% REBIT POSITIVE FOR FY23 WITH OTHER ACCELERATORS REBIT ALMOST QUADRUPLING MEDIUM TERM GUIDANCE REITERATED Louvain-la-Neuve, Belgium, 21 March...
► Artikel lesen
19.03.IBA SA: IBA signs contract to install a Be-Efficient irradiation solution in Germany145Louvain-la-Neuve, Belgium, March 19, 2024 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial irradiation...
► Artikel lesen
14.03.IBA SA: PanTera signs a second agreement for the supply of actinium-2255
29.02.IBA SA: IBA signs contract with IAEA for the installation of a Cyclone® KEY in Benin, West Africa6
26.02.IBA SA: IBA Notice of Full Year 2023 Results and Conference Call11
20.02.IBA SA: IBA - Transparency Notification7
13.02.IBA SA: PanTera signs agreement with Bayer for the supply of actinium-225519Agreement demonstrates PanTera's unique ability to support the radionuclide therapeutics industry in bringing new cancer treatments to patients Mol, Belgium, February 13, 2023: PanTera, the Belgian...
► Artikel lesen
09.02.IBA SA: IBA acquires Radcal Corporation to expand Medical Imaging Quality Assurance offering and strengthen US presence293Highly complementary acquisition continues IBA's expansion strategy to lead the Radiotherapy, Medical Imaging Dosimetry and Quality Assurance markets globally Louvain-la-Neuve, Belgium, February...
► Artikel lesen
05.02.IBA SA: IBA - Transparency Notification6
23.01.IBA SA: iThemba LABS ready to start production of Strontium-82 and Germanium-68 using IBA Cyclone® 705
12.01.CGNNT and IBA cooperate to fight cancer in China with proton therapy7
09.01.IBA SA: IBA - Regulated Information4
21.12.23IBA SA: IBA - Transparency Notification7
21.12.23IBA SA: IBA signs contract for a Proteus®ONE proton therapy system to be located at the Greater Poland Cancer Center6
20.12.23IBA SA: IBA celebrates a new milestone with the sale of the 100th Cyclone KIUBE cyclotron262The Cyclone® KIUBE is a high-performance cyclotron enabling the production of many radioisotopes used for the diagnosis of cancer and other severe cardiac and neurologic diseases Louvain-la-Neuve...
► Artikel lesen
13.12.23IBA SA: IBA, CMI and Life Molecular Imaging announce Japanese approval for the reimbursement of amyloid-PET diagnostic Neuraceq® in Alzheimer's disease5
12.12.23IBA SA: IBA pioneers theranostic advancements, empowering the market to produce Astatine-211265Rigging of the Cyclone® 30 XP in Poland completed with a further two sites in Germany and France already operational Louvain-la-Neuve, Belgium, December 12, 2023 - IBA (Ion Beam Applications S.A....
► Artikel lesen
Seite:  Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1